Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
340.00    -1.40 (-0.41%)
Bid:
340.20
Ask:
340.40
Spread: 0.20 (0.059%)
Market Cap: £2.48b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Statement re transaction with ICAP

21 Jun 2016 18:25

RNS Number : 8851B
Tullett Prebon PLC
21 June 2016
 

 

FOR IMMEDIATE RELEASE

21 June 2016

 

 

 

Tullett Prebon plc

 

 

Update on the proposed acquisition of ICAP's global hybrid voice broking and information business

 

 

Tullett Prebon plc ("Tullett Prebon") notes today's announcement by the Competition and Markets Authority (the "CMA") in relation to the proposed acquisition by Tullett Prebon of the global hybrid voice broking and information business of ICAP plc ("ICAP") (the "Transaction").

 

On 7 June the CMA announced it would refer the Transaction to a Phase 2 investigation unless suitable undertakings were offered. Tullett Prebon and ICAP have undertaken to divest ICAP's London-based oil desks (with key staff) responsible for providing broking services to customers based in Europe, Middle East & Africa to a suitable purchaser(s) to be approved by the CMA. The CMA will now consider in detail the proposed undertakings instead of referring the Transaction for an in-depth investigation.

 

Tullett Prebon and ICAP are working together to achieve the proposed divestment within the appropriate timeframe.

 

Tullett Prebon and ICAP have agreed that ICAP will no longer retain a 19.9% interest in the combined TP ICAP after completion of the Transaction and, subject to the requisite approvals, these shares will be issued directly to ICAP shareholders such that they will hold approximately 56% of the combined TP ICAP share capital on completion.

 

Other than as disclosed by Tullett Prebon, there has been no other significant change affecting any matter contained in the announcement of the Transaction on 11 November 2015 and no other significant new matter has arisen which would have been required to be mentioned in that announcement if it had arisen at the time of the preparation of that announcement.

 

Tullett Prebon remains confident that clearance from the CMA will be obtained, and the Transaction remains on track to close in 2016.

 

Enquiries

Stephen Breslin

Group Head of Communications, Tullett Prebon plc

Direct: +44(0)20 7200 7750

Email: sbreslin@tullettprebon.com

Kim Fletcher/Craig Breheny

Brunswick Group LLP

Switchboard: +44 (0) 207 404 5959

Email: tullettprebon@brunswickgroup.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRAKDDDOBKDOAB
Date   Source Headline
17th May 20235:05 pmRNSResult of AGM
17th May 20237:00 amRNSTrading Statement
13th Apr 202312:30 pmRNSHolding(s) in Company
5th Apr 20233:00 pmRNSDirector/PDMR Shareholding
4th Apr 202311:00 amRNSNotice of AGM and Committee Membership Changes
3rd Apr 20235:05 pmRNSDirector/PDMR Shareholding
29th Mar 20234:00 pmRNSHolding(s) in Company
23rd Mar 202311:00 amRNSDirector/PDMR Shareholding
22nd Mar 202311:00 amRNS2022 Annual Report and Accounts
14th Mar 20237:00 amRNSTP ICAP Group PLC - Final Results
8th Feb 20234:19 pmRNSChanges to Senior Independent Director
13th Dec 202210:00 amRNSHolding(s) in Company
6th Dec 20225:15 pmRNSHolding(s) in Company
1st Nov 20227:00 amRNSTrading Statement
27th Oct 20225:30 pmRNSHolding(s) in Company
25th Oct 20225:50 pmRNSHolding(s) in Company
13th Sep 20225:32 pmRNSHolding(s) in Company
10th Aug 20227:00 amRNSHalf-year Report
28th Jul 20225:22 pmRNSResult of External Audit Tender
30th Jun 20225:44 pmRNSHolding(s) in Company
27th May 20223:30 pmRNSDirector/PDMR Shareholding
11th May 20226:01 pmRNSResult of AGM
11th May 20227:00 amRNSTrading Statement
4th May 20224:27 pmRNSGrant of Options and Director/PDMR Shareholding
22nd Apr 20224:49 pmRNSHolding(s) in Company
11th Apr 20224:17 pmRNSHolding(s) in Company
5th Apr 202211:02 amRNSAnnual Financial Report
4th Apr 20224:03 pmRNSDirector/PDMR Shareholding
31st Mar 20226:03 pmRNSDirector/PDMR Shareholding
29th Mar 20225:44 pmRNSHolding(s) in Company
15th Mar 20227:00 amRNSFinal Results
11th Jan 202211:35 amRNSHolding(s) in Company
22nd Dec 20215:00 pmRNSAppointment of new director
13th Dec 20213:24 pmRNSDirector/PDMR Shareholding
12th Nov 20212:04 pmRNSShareholder meeting update and PDMR transactions
12th Nov 20211:57 pmRNSTotal Voting Rights
2nd Nov 20217:00 amRNSTrading update - three months ended 30/09/2021
11th Oct 20214:00 pmRNSDirector/PDMR Shareholding
11th Oct 20213:01 pmRNSParameta Solutions Investor Seminar
7th Oct 202110:40 amRNSDirector/PDMR Shareholding
20th Sep 20214:58 pmRNSDirector/PDMR Shareholding
8th Sep 20215:08 pmRNSDirector/PDMR Shareholding
7th Sep 20217:00 amRNSHalf-year Report
3rd Aug 20217:00 amRNSTrading Statement
22nd Jun 20214:36 pmRNSDirector/PDMR Shareholding
18th May 202111:20 amRNSDirector/PDMR Shareholding
12th May 20215:49 pmRNSResult of AGM
12th May 20217:00 amRNSTrading Statement
23rd Apr 20215:10 pmRNSGrant of Options and Director/PDMR Shareholding
6th Apr 20214:32 pmRNSDirector/PDMR Shareholding - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.